This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Enterohepatic circulation is a process in which substances, such as drugs and hormones, are absorbed by the small intestine, undergo metabolism in the liver, and are then reabsorbed by the intestine and returned to the liver. This process is important because it helps to regulate the level of certain compounds in the body, such as bile salts, nutrients, and drugs. The first stage of enterohepatic circulation is absorption. The small intestine absorbs the compounds and transports them to the liver via the hepatic portal vein. Once in the liver, the compounds are metabolized by the liver enzymes. This process is known as “first-pass metabolism” and helps to regulate the levels of certain compounds in the body. The second stage of enterohepatic circulation is the reabsorption of the compounds. The metabolites of the compounds are reabsorbed by the small intestine and transported back to the liver via the hepatic portal vein. This allows the body to regulate the level of certain compounds and maintain homeostasis. The third stage of enterohepatic circulation is the excretion of the metabolites. The metabolites are excreted from the body via either the bile duct or the urine. This helps to maintain a balance between the compounds that enter and leave the body. Enterohepatic circulation is an important process in the body, as it helps to regulate the levels of certain compounds in the body. Without this process, the levels of certain compounds in the body could become too high or too low, leading to a variety of health problems.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States